Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma”

8,273 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,273 results

Large-scale testing (Phase 3)Ended earlyNCT05247307
What this trial is testing

Efficacy of the Infusion of Donor Plasma in COVID-19 Infection

Who this might be right for
COVID-19
Hospital Galdakao-Usansolo 93
Early research (Phase 1)Study completedNCT01241292
What this trial is testing

Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 7
Early research (Phase 1)Study completedNCT04868292
What this trial is testing

Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Spero Therapeutics 34
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Early research (Phase 1)Study completedNCT04163107
What this trial is testing

Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 19
Not applicableUnknownNCT04496011
What this trial is testing

Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
FatigueLeukemiaLymphoma+2 more
Federal University of Health Science of Porto Alegre 30
Not applicableEnded earlyNCT00332371
What this trial is testing

COMPACT - COMbining Plasma-filtration and Adsorption Clinical Trial

Who this might be right for
Shock, Septic
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva 184
Not applicableLooking for participantsNCT07784907
What this trial is testing

Efficacy of Platelet-Rich Plasma Combined With Hyaluronic Acid in Knee Osteoarthritis

Who this might be right for
Knee OsteoarthritisKnee Osteoarthritis (Knee OA)Knee Osteoarthritis (OA)+1 more
Implai Sp z o.o 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT06304636
What this trial is testing

Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaRelapsed Multiple Myeloma
Cartesian Therapeutics 4
Testing effectiveness (Phase 2)Study completedNCT02768207
What this trial is testing

Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 40
Early research (Phase 1)Active Not RecruitingNCT05363800
What this trial is testing

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

Who this might be right for
Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
Jiangsu HengRui Medicine Co., Ltd. 74
Post-approval studies (Phase 4)Looking for participantsNCT03734900
What this trial is testing

Comparison of Effectiveness Between PL and PRP on Knee Osteoarthritis: a Prospective,Randomized,Placebo-controlled Trial

Who this might be right for
Osteoarthritis (OA) of the Knee
National Taiwan University Hospital 150
Post-approval studies (Phase 4)Study completedNCT02241044
What this trial is testing

Argon Plasma Coagulation for Bleeding Peptic Ulcers

Who this might be right for
Bleeding Ulcers
Kaohsiung Veterans General Hospital. 116
Not applicableStudy completedNCT03955900
What this trial is testing

A Registry Study of Participants With Multiple Myeloma in Latin America

Who this might be right for
Multiple Myeloma
Janssen-Cilag Ltd. 2,059
Testing effectiveness (Phase 2)Looking for participantsNCT07032792
What this trial is testing

Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery

Who this might be right for
Cardiac DiseaseSurgeryBleeding
Northwell Health 140
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Not applicableLooking for participantsNCT00071526
What this trial is testing

Urinary Vitamin C Loss in Diabetic Subjects

Who this might be right for
Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5,000
Next Page